MedAI Verdict
Billing & coding

AI Medical Billing

Sift Healthcare RevProtect logo

Sift Healthcare RevProtect

by Sift Healthcare  ·  founded 2017  ·  US

Last verified

RevProtect predicts underpayments, denials and DRG downgrade risk for hospital revenue integrity teams.

At a glance

Pricing
No public price. Site CTA is "Request a Demo".
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2017
HQ
US
On this page

Independent score  ·  By our public rubric

16/100Tracked

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    0/10

    No public HIPAA/SOC2/BAA attestation

  • Clinical Integration
    0/31.4

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    9/18

    Founded 2017 (9 years)

  • Sentiment & Transparency
    3.3/6.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/18

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    Seed-stage or unfunded

  • Years in market6/6

    Founded 2017 (9 years)

Sentiment & Transparency

  • Pricing transparency3/7

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

RevProtect predicts underpayments, denials and DRG downgrade risk for hospital revenue integrity teams.

No public price. Site CTA is "Request a Demo".

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Sift Healthcare RevProtect record, https://medaiverdict.com/tools/sift-healthcare, version November 2, 2026

Bottom line

Sift Healthcare, based in Milwaukee, describes RevProtect as "payment intelligence that predicts, prevents, and resolves reimbursement risk for health systems," turning clinical and payments data into next-best actions across utilization review, CDI, coding and patient financial services. Hospitals and health systems are the customers, and the homepage names those four teams as the users. Whether the models are classical machine learning or include large language models is not stated.

Prediction before the bill

The reimbursement risk prediction page says the models cover underpayments, DRG downgrades and clinical takeback probability "as care is documented," in pre-bill, from clinical, 837 and 835 data. The denials page calls the product "a denial prevention solution for hospitals and health systems" that "predicts and prevents claim denials before submission."

Recommendations and deployment paths

For each at-risk case, the actionable recommendations page lists documentation gaps, tests or assessments needed, provider query details and supporting material for claims and appeals. The homepage adds denial intelligence and prioritization, plus validation and learning with ROI metrics.

Three deployment paths appear on the homepage: use Sift's own interface, embed in existing tools (the EHR or a third party) as worklists, or work through a partner. The homepage names no EHR vendor.

Customers and the 88 health systems

The homepage claims "Sift intelligence deployed across 88 health systems," "329 proprietary MS-DRG playbooks," "692 normalized clinical + financial data elements" and "10,000+ data points analyzed across the full claims lifecycle." The about page states the company's thesis: "Denials persist around 15% despite waves of 'AI solutions'."

Hartford Healthcare and ProHealth Care appear as case-study logos. Their documents, "Driving Denial Reduction And Revenue Recovery Improvement" and "ML-Driven Denials Intelligence," sit behind a form. Sift also publishes an annual Denials Insights Report, which is vendor research.

Outside Sift's own material, PubMed lists 0 results for "RevProtect."

Funding and location, as reported

Justin Nicols founded Sift in 2017 and is CEO, according to BizTimes and Tracxn coverage. BizTimes reported a US$20M Series B led by B Capital in about May 2024, with Allos Ventures, First Trust Capital Partners and Rock River Capital. The Series A is reported at $6.75M by BizTimes and $9M by FinSMEs (July 2022), and aggregators put total funding between $32.5M and $41.96M.

Security pages

The homepage, the reimbursement risk prediction page and the actionable recommendations page state no HIPAA, BAA, SOC 2 or HITRUST status. A privacy policy exists at /privacy-policy.

No listed price

Sift lists no price, and the call to action is "Request a Demo."

The verdict

RevProtect suits a hospital whose utilization review, CDI, coding and patient financial services teams want denial and downgrade risk flagged before billing, with recommendations and prioritization on each case. Sift's pages describe prediction and recommendations, so a team that wants codes assigned automatically has a gap to fill.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Site CTA is "Request a Demo".

Source: vendor pricing page. Last checked November 2, 2026.

Who builds it

Sift Healthcare RevProtect (Sift Healthcare) was founded in 2017 in US, putting it 9 years into market.